Predisposition to viral infection of the fetus and neonate

Maya I Rhyn1, Angela Castellano1, Valeria Cortesi2

  • 1Neonatal and Pediatric Intensive Care Unit, Mother, Child and Adolescent Department, Geneva University Hospitals, Geneva, Switzerland.

PubMed

Insights

Infants face higher risks from viral infections due to unique immune vulnerabilities. Understanding inborn errors of immunity and auto-antibodies is key to developing new treatments for severe early-life viral diseases.

Area of Science:

  • Immunology
  • Virology
  • Neonatology

Background:

  • Infants exhibit heightened susceptibility to viral infections, leading to severe disease and mortality.
  • Interindividual variability in clinical outcomes suggests factors beyond maternal immunity are involved.
  • Inborn errors of immunity and auto-antibodies neutralizing type I interferons (IFNs) are recognized causes of severe viral disease.

Purpose of the Study:

  • To investigate the role of inborn errors of antiviral immunity in early-life viral diseases.
  • To explore the significance of auto-antibodies neutralizing type I IFNs in neonatal viral infections.
  • To understand the molecular mechanisms underlying severe viral disease in newborns and infants.

Main Methods:

  • Review of existing literature on inborn errors of immunity and auto-antibodies in viral diseases.
  • Analysis of neonatal immune system specificities and maternal immune interactions.
  • Inference from studies of viral disease in older individuals to understand early-life immunity.

Main Results:

  • Inborn errors of immunity contribute to severe viral disease in infants.
  • Auto-antibodies against type I IFNs are critical determinants of viral disease severity.
  • Early-life viral disease pathogenesis involves complex interactions within the neonatal immune system.

Conclusions:

  • Investigating inborn errors of antiviral immunity and auto-antibodies is crucial for understanding infant viral disease.
  • Effective prevention and treatment strategies require consideration of the neonatal immune system's unique characteristics.
  • Further research is needed to elucidate the specific roles of these factors in early-life viral infections.

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.1K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.4K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
2.7K
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
14.3K
Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
4.4K
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
2.3K